Ost-müük BIOLASE - BIOL CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | 0.14 | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.024068% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.001846% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Eelmine sulgemine* | 4.54 |
Avatud* | 4.38 |
Aastane muutus* | 1.62% |
Päeva ulatus* | 4.26 - 4.58 |
52 nädala ulatus | 0.30-9.24 |
Keskmine maht (10 päeva) | 271.41K |
Keskmine maht (3 kuud) | 11.89M |
Turukapitalisatsioon | 12.04M |
P/E suhtarv | -100.00K |
Ringluses olevad aktsiad | 35.58M |
Tulu | 46.82M |
EPS | -3.68 |
Dividendid (% kasumist) | N/A |
Beeta | 1.44 |
Järgmine tuluaruande kuupäev | Mar 28, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|---|---|---|---|---|---|
Jun 29, 2022 | 4.30 | -0.08 | -1.83% | 4.38 | 4.58 | 4.22 |
Jun 28, 2022 | 4.54 | 0.32 | 7.58% | 4.22 | 5.00 | 4.22 |
Jun 27, 2022 | 5.08 | 0.86 | 20.38% | 4.22 | 5.19 | 4.22 |
Jun 24, 2022 | 4.47 | 0.25 | 5.92% | 4.22 | 4.60 | 4.22 |
Jun 23, 2022 | 4.19 | 0.12 | 2.95% | 4.07 | 4.30 | 4.07 |
Jun 22, 2022 | 4.05 | -0.27 | -6.25% | 4.32 | 4.52 | 3.99 |
Jun 21, 2022 | 4.32 | 0.04 | 0.93% | 4.28 | 4.53 | 4.16 |
Jun 17, 2022 | 4.51 | 0.22 | 5.13% | 4.29 | 4.51 | 4.29 |
Jun 16, 2022 | 4.17 | -0.01 | -0.24% | 4.18 | 4.37 | 4.16 |
Jun 15, 2022 | 4.26 | 0.19 | 4.67% | 4.07 | 4.26 | 4.07 |
Jun 14, 2022 | 4.26 | 0.17 | 4.16% | 4.09 | 4.37 | 4.09 |
Jun 13, 2022 | 4.10 | -0.17 | -3.98% | 4.27 | 4.34 | 4.07 |
Jun 10, 2022 | 4.56 | -0.06 | -1.30% | 4.62 | 4.62 | 4.47 |
Jun 9, 2022 | 4.67 | 0.03 | 0.65% | 4.64 | 4.76 | 4.64 |
Jun 8, 2022 | 4.63 | 0.01 | 0.22% | 4.62 | 4.71 | 4.59 |
Jun 7, 2022 | 4.64 | 0.02 | 0.43% | 4.62 | 4.73 | 4.62 |
Jun 6, 2022 | 4.67 | 0.03 | 0.65% | 4.64 | 4.79 | 4.59 |
Jun 3, 2022 | 4.82 | 0.20 | 4.33% | 4.62 | 4.90 | 4.62 |
Jun 2, 2022 | 4.67 | 0.04 | 0.86% | 4.63 | 4.80 | 4.61 |
Jun 1, 2022 | 4.63 | -0.15 | -3.14% | 4.78 | 4.78 | 4.57 |
BIOLASE Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
No events scheduled |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Kogutulu | 39.188 | 22.78 | 37.799 | 46.155 | 46.926 |
Tulu | 39.188 | 22.78 | 37.799 | 46.155 | 46.926 |
Kulud, Kokku | 22.659 | 16.607 | 23.511 | 29.26 | 31.8 |
Brutokasum | 16.529 | 6.173 | 14.288 | 16.895 | 15.126 |
Kogu tegevuskulu | 52.605 | 41.316 | 53.42 | 67.04 | 64.964 |
Müük/Üldine/admin kulud, kokku | 26.597 | 21.014 | 25.144 | 29.892 | 26.43 |
Uuringud ja arendus | 6.048 | 3.695 | 4.765 | 5.203 | 6.229 |
Ootamatud kulutused (tulu) | -2.699 | 0 | 0 | 2.685 | 0.505 |
Tulud majandustegevusest | -13.417 | -18.536 | -15.621 | -20.885 | -18.038 |
Intressitulud (kulu), muud tulud, neto | -2.676 | -2.38 | -2.278 | -0.568 | 0.605 |
Netotulu enne makse | -16.093 | -16.701 | -17.899 | -21.453 | -17.433 |
Netotulu pärast makse | -16.158 | -16.829 | -17.855 | -22.116 | 4.249 |
Netotulu enne erikulusid | -16.158 | -16.829 | -17.855 | -22.116 | 4.249 |
Netotulu | -16.158 | -16.829 | -17.855 | -21.516 | -16.851 |
Total Adjustments to Net Income | -0.546 | -17.378 | 0 | 0 | -3.978 |
Arvestatav tulu, v a erikulud | -16.704 | -34.207 | -17.855 | -22.116 | 0.271 |
Arvestatav tulu, koos erikuludega | -16.704 | -34.207 | -17.855 | -21.516 | -20.829 |
Jaotamisele kuuluv netotulu | -16.704 | -34.207 | -17.855 | -21.516 | -20.829 |
Keskmine jaotamisele kuuluv aktsia kohta | 5.90984 | 2.44544 | 0.92804 | 0.82352 | 0.59007 |
Jaotatav EPS, v a erakorralised kulud | -2.82647 | -13.9881 | -19.2395 | -26.8554 | 0.45927 |
Jaotamisele kuuluv normaal-EPS | -3.12332 | -13.9881 | -19.2395 | -24.7362 | 1.01555 |
Erakorralised kulud kokku | 0.6 | -21.1 | |||
Muud, neto | 0 | 4.215 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Kogutulu | 10.166 | 12.408 | 9.531 | 9.134 | 8.116 |
Tulu | 10.166 | 12.408 | 9.531 | 9.134 | 8.116 |
Kulud, Kokku | 5.437 | 7.502 | 4.689 | 5.093 | 5.375 |
Brutokasum | 4.729 | 4.906 | 4.842 | 4.041 | 2.741 |
Kogu tegevuskulu | 14.372 | 16.838 | 12.188 | 9.403 | 14.178 |
Müük/Üldine/admin kulud, kokku | 7.391 | 7.669 | 5.93 | 6.09 | 7 |
Uuringud ja arendus | 1.544 | 1.542 | 1.54 | 1.162 | 1.803 |
Tulud majandustegevusest | -4.206 | -4.43 | -2.657 | -0.269 | -6.062 |
Intressitulud (kulu), muud tulud, neto | -0.553 | -0.777 | -0.605 | -0.513 | -0.779 |
Netotulu enne makse | -4.759 | -5.207 | -3.262 | -0.782 | -6.841 |
Netotulu pärast makse | -4.776 | -5.279 | -3.276 | -0.702 | -6.901 |
Netotulu enne erikulusid | -4.776 | -5.279 | -3.276 | -0.702 | -6.901 |
Netotulu | -4.776 | -5.279 | -3.276 | -0.702 | -6.901 |
Total Adjustments to Net Income | -0.217 | 0 | -0.009 | -0.006 | -0.532 |
Arvestatav tulu, v a erikulud | -4.993 | -5.279 | -3.285 | -0.708 | -7.433 |
Arvestatav tulu, koos erikuludega | -4.993 | -5.279 | -3.285 | -0.708 | -7.433 |
Jaotamisele kuuluv netotulu | -4.993 | -5.279 | -3.285 | -0.708 | -7.433 |
Keskmine jaotamisele kuuluv aktsia kohta | 6.159 | 6.14228 | 6.07764 | 6.0266 | 5.38344 |
Jaotatav EPS, v a erakorralised kulud | -0.81068 | -0.85945 | -0.54051 | -0.11748 | -1.38072 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Jaotamisele kuuluv normaal-EPS | -0.81068 | -0.84622 | -0.5374 | -0.43479 | -1.38072 |
Ootamatud kulutused (tulu) | 0.125 | 0.029 | -2.942 | ||
Muud, neto | 0 | 0 |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Käibevarad kokku | 49.354 | 35.11 | 27.019 | 33.307 | 36.05 |
Raha ja lühiajalised investeeringud | 29.972 | 17.564 | 5.789 | 8.044 | 11.645 |
Raha ja ekvivalendid | 29.972 | 17.564 | 5.789 | 8.044 | 11.645 |
Laekumata arved, neto | 4.238 | 3.059 | 8.76 | 11.112 | 10.124 |
Accounts Receivable - Trade, Net | 4.238 | 3.059 | 8.76 | 10.99 | 10.047 |
Total Inventory | 12.929 | 11.157 | 10.995 | 12.248 | 12.298 |
Prepaid Expenses | 2.012 | 3.018 | 1.163 | 1.591 | 1.732 |
Other Current Assets, Total | 0.203 | 0.312 | 0.312 | 0.312 | 0.251 |
Total Assets | 55.284 | 41.025 | 31.847 | 38.516 | 42.984 |
Property/Plant/Equipment, Total - Net | 2.784 | 2.758 | 1.469 | 1.975 | 3.674 |
Property/Plant/Equipment, Total - Gross | 10.833 | 10.422 | 10.791 | 10.319 | 11.1 |
Accumulated Depreciation, Total | -8.049 | -7.664 | -9.322 | -8.344 | -7.426 |
Goodwill, Net | 2.926 | 2.926 | 2.926 | 2.926 | 2.926 |
Intangibles, Net | 0 | 0 | 0 | 0 | 0 |
Other Long Term Assets, Total | 0.22 | 0.231 | 0.433 | 0.308 | 0.334 |
Total Current Liabilities | 13.844 | 11.223 | 25.779 | 15.967 | 13.37 |
Accounts Payable | 3.309 | 2.651 | 5.332 | 5.953 | 5.109 |
Accrued Expenses | 6.619 | 5.771 | 3.79 | 6.133 | 4.689 |
Notes Payable/Short Term Debt | 0 | 0 | 13.466 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | ||||
Other Current Liabilities, Total | 3.916 | 2.801 | 3.191 | 3.881 | 3.572 |
Total Liabilities | 30.076 | 30.997 | 27.505 | 27.427 | 13.724 |
Total Long Term Debt | 13.603 | 16.186 | 0 | 10.836 | 0 |
Capital Lease Obligations | |||||
Deferred Income Tax | 0.078 | 0.077 | 0.104 | ||
Other Liabilities, Total | 2.629 | 3.588 | 1.648 | 0.547 | 0.25 |
Total Equity | 25.208 | 10.028 | 4.342 | 11.089 | 29.26 |
Common Stock | 0.154 | 0.098 | 0.031 | 0.021 | 0.102 |
Additional Paid-In Capital | 293.177 | 261.573 | 235.594 | 228.43 | 224.91 |
Retained Earnings (Accumulated Deficit) | -267.534 | -251.376 | -234.547 | -216.692 | -195.176 |
Other Equity, Total | -0.623 | -0.385 | -0.701 | -0.67 | -0.576 |
Total Liabilities & Shareholders’ Equity | 55.284 | 41.025 | 31.847 | 38.516 | 42.984 |
Total Common Shares Outstanding | 6.14704 | 3.90654 | 1.25756 | 0.8429 | 0.81872 |
Long Term Debt | 13.603 | 16.186 | 0 | 10.836 | |
Redeemable Preferred Stock | 3.965 | ||||
Total Preferred Shares Outstanding | 0 | 0 | 0.07 | ||
Preferred Stock - Non Redeemable, Net | 0.034 | 0.118 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Käibevarad kokku | 43.783 | 49.354 | 52.654 | 55.34 | 57.749 |
Raha ja lühiajalised investeeringud | 21.606 | 29.972 | 33.385 | 37.081 | 40.842 |
Raha ja ekvivalendid | 21.606 | 29.972 | 33.385 | 37.081 | 40.842 |
Laekumata arved, neto | 5.18 | 4.238 | 3.637 | 3.819 | 3.266 |
Accounts Receivable - Trade, Net | 5.18 | 4.238 | 3.637 | 3.819 | 3.266 |
Total Inventory | 14.611 | 12.929 | 14.062 | 12.715 | 11.877 |
Prepaid Expenses | 2.183 | 2.012 | 1.366 | 1.521 | 1.56 |
Other Current Assets, Total | 0.203 | 0.203 | 0.204 | 0.204 | 0.204 |
Total Assets | 50.242 | 55.284 | 58.514 | 61.249 | 63.484 |
Property/Plant/Equipment, Total - Net | 3.302 | 2.784 | 2.712 | 2.758 | 2.583 |
Property/Plant/Equipment, Total - Gross | 11.469 | 10.833 | 10.643 | 10.587 | 10.324 |
Accumulated Depreciation, Total | -8.167 | -8.049 | -7.931 | -7.829 | -7.741 |
Goodwill, Net | 2.926 | 2.926 | 2.926 | 2.926 | 2.926 |
Other Long Term Assets, Total | 0.231 | 0.22 | 0.222 | 0.225 | 0.226 |
Total Current Liabilities | 13.112 | 13.844 | 13.457 | 12.719 | 11.27 |
Accounts Payable | 4.643 | 3.309 | 3.597 | 3.502 | 3.072 |
Accrued Expenses | 5.167 | 6.619 | 4.929 | 5.174 | 5.386 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0.7 | 0 |
Other Current Liabilities, Total | 3.302 | 3.916 | 3.531 | 3.343 | 2.812 |
Total Liabilities | 29.642 | 30.076 | 28.192 | 27.993 | 29.968 |
Total Long Term Debt | 13.666 | 13.603 | 12.114 | 12.703 | 16.295 |
Long Term Debt | 13.666 | 13.603 | 12.114 | 12.703 | 16.295 |
Other Liabilities, Total | 2.864 | 2.629 | 2.621 | 2.571 | 2.403 |
Total Equity | 20.6 | 25.208 | 30.322 | 33.256 | 33.516 |
Preferred Stock - Non Redeemable, Net | 0 | 0.034 | 0.034 | 0.035 | 0.036 |
Common Stock | 0.155 | 0.154 | 0.153 | 0.151 | 0.149 |
Additional Paid-In Capital | 293.419 | 293.177 | 292.948 | 292.517 | 292.141 |
Retained Earnings (Accumulated Deficit) | -272.31 | -267.534 | -262.255 | -258.979 | -258.277 |
Other Equity, Total | -0.664 | -0.623 | -0.558 | -0.468 | -0.533 |
Total Liabilities & Shareholders’ Equity | 50.242 | 55.284 | 58.514 | 61.249 | 63.484 |
Total Common Shares Outstanding | 6.176 | 6.14704 | 6.13108 | 6.04944 | 5.97652 |
Total Preferred Shares Outstanding | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 1.4 |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Netotulu/algväärtus | -16.158 | -16.829 | -17.855 | -21.516 | -16.851 |
Raha majandustegevusest | -16.71 | -12.795 | -12.746 | -14.147 | -18.412 |
Raha majandustegevusest | 0.4 | 0.499 | 0.982 | 0.945 | 1.203 |
Deferred Taxes | 0.007 | -0.027 | -0.694 | ||
Mittelikviidsed varad | 0.985 | 1.781 | 5.228 | 6.46 | 3.333 |
Cash Taxes Paid | 0.171 | 0.022 | 0.035 | 0.044 | 0.164 |
Makstud intressid | 1.771 | 1.881 | 1.784 | 0.023 | 0.001 |
Muutused tööjõus | -1.937 | 1.754 | -1.108 | -0.009 | -5.403 |
Tulu investeeringutelt | -0.707 | -0.096 | -0.207 | -0.522 | -0.747 |
Kapitalikulutused | -0.707 | -0.096 | -0.207 | -0.558 | -0.747 |
Muud rahavood investeeringutelt, kokku | 0 | 0.036 | 0 | ||
Rahavood investeeringutelt | 29.954 | 24.349 | 10.721 | 11.235 | 21.618 |
Rahavoogudesse investeerimine | -1.135 | -3.049 | -0.954 | -1.222 | 0 |
Aktsiate emiteerimine (tagasiost), neto | 31.114 | 24.958 | 9.175 | 0.003 | 21.764 |
Laenu väljastamine (kustutamine), neto | -0.025 | 2.44 | 2.5 | 12.454 | -0.146 |
Muutused valuutakursside kõikumisest | -0.238 | 0.317 | -0.023 | -0.106 | 0.262 |
Rahaline kogumuutus | 12.299 | 11.775 | -2.255 | -3.54 | 2.721 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -4.776 | -16.158 | -10.879 | -7.603 | -6.901 |
Cash From Operating Activities | -8.021 | -16.71 | -13.606 | -10.008 | -6.499 |
Cash From Operating Activities | 0.117 | 0.4 | 0.281 | 0.176 | 0.085 |
Deferred Taxes | 0 | ||||
Non-Cash Items | 0.42 | 0.985 | -1.035 | -1.461 | 1.118 |
Cash Taxes Paid | 0.026 | 0.171 | 0.154 | 0.13 | 0.01 |
Cash Interest Paid | 0.377 | 1.771 | 1.328 | 0.886 | 0.448 |
Changes in Working Capital | -3.782 | -1.937 | -1.973 | -1.12 | -0.801 |
Cash From Investing Activities | -0.304 | -0.707 | -0.396 | -0.311 | -0.008 |
Capital Expenditures | -0.304 | -0.707 | -0.396 | -0.311 | -0.008 |
Cash From Financing Activities | 0 | 29.954 | 29.886 | 29.811 | 29.825 |
Financing Cash Flow Items | 0 | -1.135 | -0.006 | -0.006 | -0.006 |
Issuance (Retirement) of Stock, Net | 0 | 31.114 | 29.917 | 29.841 | 29.831 |
Foreign Exchange Effects | -0.041 | -0.238 | -0.171 | -0.083 | -0.148 |
Net Change in Cash | -8.366 | 12.299 | 15.713 | 19.409 | 23.17 |
Issuance (Retirement) of Debt, Net | -0.025 | -0.025 | -0.024 |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group500K+
Kauplejad
92K+
Igakuiste aktiivsete klientide arv
$53M+
Igakuine investeerimise maht
$30M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
BIOLASE Company profile
Ettevõttest BIOLASE
BIOLASE, Inc. on kõrgtehnoloogiliste lasersüsteemide pakkuja hambaravitööstusele. Ettevõte arendab, toodab, turustab ja müüb lasersüsteeme, mis aitavad hambaarste ja nende patsiente. Ettevõtte süsteemid võimaldavad hambaarstidel, parodontoloogidel, endodontoloogidel, lastehambaarstidel, suukirurgidel ja muudel hambaravi spetsialistidel teha mitmesuguseid hambaravi protseduure, sealhulgas kosmeetilisi, restauratiivseid ja keerulisi kirurgilisi rakendusi. Ettevõte pakub kahte kategooriat lasersüsteemide tooteid: Waterlase-süsteemid (kõik koed) ja dioodisüsteemid (pehmed koed). Waterlase kasutab patenteeritud vee ja lasrigenergia kombinatsiooni ning kasutab pehmete ja kõvade kudede lõikamiseks puuride, skalpellide ja muude traditsiooniliste hambaraviinstrumentide kasutamist. Ta pakub oma dioodlasersüsteeme pehmete kudede, valuravi ja kosmeetiliste protseduuride, sealhulgas hammaste valgendamise teostamiseks. Ettevõttel on ligikaudu 301 väljaantud ja 38 menetluses olevat Ameerika Ühendriikide ja rahvusvahelist patenti.
Industry: | Advanced Medical Equipment & Technology (NEC) |
27042 Towne Centre Drive
Suite 270
FOOTHILL RANCH
CALIFORNIA 92610
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 500,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com